Topics

Human medicines European public assessment report (EPAR): Ivabradine Anpharm, ivabradine, Angina Pectoris,Heart Failure, Date of authorisation: 08/09/2015, Revision: 5, Status: Authorised

09:40 EST 7 Nov 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Ivabradine Anpharm, ivabradine, Angina Pectoris,Heart Failure, Date of authorisation: 08/09/2015, Revision: 5, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Ivabradine Anpharm, ivabradine, Angina Pectoris,Heart Failure, Date of authorisation: 08/09/2015, Revision: 5, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Ivabradine Anpharm, ivabradine, Angina Pectoris,Heart Failure, Date of authorisation: 08/09/2015, Revision: 5, Status: Authorised"

Quick Search

Relevant Topic

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...